Cronos Group Inc - Asset Resilience Ratio
Cronos Group Inc (CRON) has an Asset Resilience Ratio of 69.94% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Cronos Group Inc total liabilities for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2016–2024)
This chart shows how Cronos Group Inc's Asset Resilience Ratio has changed over time. See net assets of Cronos Group Inc for net asset value and shareholders' equity analysis.
Liquid Assets Composition Over Time
This chart breaks down Cronos Group Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Cronos Group Inc stock valuation.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CA$784.17 Million | 66.54% |
| Short-term Investments | CA$40.00 Million | 3.39% |
| Total Liquid Assets | CA$824.17 Million | 69.94% |
Asset Resilience Insights
- Very High Liquidity: Cronos Group Inc maintains exceptional liquid asset reserves at 69.94% of total assets.
- This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
Cronos Group Inc Industry Peers by Asset Resilience Ratio
Compare Cronos Group Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Daihan Pharmaceutical Co.Ltd
KQ:023910 |
Drug Manufacturers - Specialty & Generic | 11.95% |
|
Aurobindo Pharma Limited
NSE:AUROPHARMA |
Drug Manufacturers - Specialty & Generic | 16.92% |
|
China Resources Sanjiu Medical & Pharmaceutical Co Ltd
SHE:000999 |
Drug Manufacturers - Specialty & Generic | 5.22% |
|
Ningbo Menovo Pharm Co Ltd
SHG:603538 |
Drug Manufacturers - Specialty & Generic | 2.69% |
|
Zhejiang Xianju Pharmaceutical Co Ltd
SHE:002332 |
Drug Manufacturers - Specialty & Generic | 6.02% |
|
Qianjiang Yongan Pharmaceutical Co Ltd
SHE:002365 |
Drug Manufacturers - Specialty & Generic | 30.38% |
|
Hainan Honz Pharmaceutical Co
SHE:300086 |
Drug Manufacturers - Specialty & Generic | 0.27% |
|
Guangdong Lifestrong Pharmacy Co. Ltd.
SHE:301111 |
Drug Manufacturers - Specialty & Generic | 7.85% |
Annual Asset Resilience Ratio for Cronos Group Inc (2016–2024)
The table below shows the annual Asset Resilience Ratio data for Cronos Group Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 73.63% | CA$858.80 Million ≈ $621.25 Million |
CA$1.17 Billion ≈ $843.69 Million |
-1.93pp |
| 2023-12-31 | 75.57% | CA$861.53 Million ≈ $623.22 Million |
CA$1.14 Billion ≈ $824.72 Million |
+3.21pp |
| 2022-12-31 | 72.36% | CA$877.72 Million ≈ $634.93 Million |
CA$1.21 Billion ≈ $877.47 Million |
+0.48pp |
| 2021-12-31 | 71.88% | CA$1.00 Billion ≈ $726.75 Million |
CA$1.40 Billion ≈ $1.01 Billion |
+4.90pp |
| 2020-12-31 | 66.98% | CA$1.29 Billion ≈ $933.01 Million |
CA$1.93 Billion ≈ $1.39 Billion |
-5.07pp |
| 2019-12-31 | 72.04% | CA$1.51 Billion ≈ $1.09 Billion |
CA$2.09 Billion ≈ $1.51 Billion |
+59.56pp |
| 2018-12-31 | 12.48% | CA$23.93 Million ≈ $17.31 Million |
CA$191.71 Million ≈ $138.68 Million |
+3.78pp |
| 2017-12-31 | 8.70% | CA$6.99 Million ≈ $5.06 Million |
CA$80.34 Million ≈ $58.12 Million |
+0.46pp |
| 2016-12-31 | 8.24% | CA$2.63 Million ≈ $1.90 Million |
CA$31.92 Million ≈ $23.09 Million |
-- |
About Cronos Group Inc
Cronos Group Inc., a cannabinoid company, engages in the cultivation, production, distribution, and marketing of cannabis products in Canada, Israel, and internationally. It offers dried flowers, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brand names. The company is based in Stayner, Canada.